| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | chromosome organization | ATRX PRICKLE1 CHMP5 DLGAP5 TEX15 RFC1 EZH1 ZRANB3 BLM SYCP2 RESF1 NUP133 KIF14 CDK5RAP2 POLQ NIPBL GOLGA2 KNL1 | 7.73e-07 | 686 | 138 | 18 | GO:0051276 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | RSPH4A ATRX PRICKLE1 CHMP5 DLGAP5 CFAP43 CNTLN DNAH1 TTLL6 GCC2 SYNE2 CCSER2 PKD2 PAK1 KIF14 CDK5RAP2 MARK2 GOLGA2 | 1.54e-06 | 720 | 138 | 18 | GO:0000226 |
| GeneOntologyBiologicalProcess | microtubule-based process | SEMG1 CFAP251 RSPH4A ATRX PRICKLE1 CHMP5 DLGAP5 CFAP43 CNTLN LYST DNAH1 TTLL6 GCC2 SYNE2 CCSER2 PKD2 PAK1 KIF14 CDK5RAP2 MARK2 GOLGA2 | 7.45e-06 | 1058 | 138 | 21 | GO:0007017 |
| GeneOntologyBiologicalProcess | replication fork processing | 2.52e-05 | 52 | 138 | 5 | GO:0031297 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication maintenance of fidelity | 5.07e-05 | 60 | 138 | 5 | GO:0045005 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid segregation | 9.23e-05 | 212 | 138 | 8 | GO:0000070 | |
| GeneOntologyCellularComponent | cytoplasmic region | CFAP251 CFAP276 EFCAB6 RSPH4A CEP162 CFAP43 DNAH1 PKD2 UNC13C MARK2 | 1.60e-04 | 360 | 140 | 10 | GO:0099568 |
| GeneOntologyCellularComponent | muscle thin filament tropomyosin | 2.65e-04 | 4 | 140 | 2 | GO:0005862 | |
| GeneOntologyCellularComponent | sarcomere | 2.80e-04 | 249 | 140 | 8 | GO:0030017 | |
| GeneOntologyCellularComponent | supramolecular fiber | TPM1 TPM2 CFAP276 DCDC1 EFCAB6 CEP162 CHMP5 SYNPO2L NEB DNAH1 DES TTLL6 UNC45B SYNE2 PAK1 KIF14 CDK5RAP2 MARK2 GOLGA2 | 3.35e-04 | 1179 | 140 | 19 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | TPM1 TPM2 CFAP276 DCDC1 EFCAB6 CEP162 CHMP5 SYNPO2L NEB DNAH1 DES TTLL6 UNC45B SYNE2 PAK1 KIF14 CDK5RAP2 MARK2 GOLGA2 | 3.64e-04 | 1187 | 140 | 19 | GO:0099081 |
| GeneOntologyCellularComponent | axoneme | 4.99e-04 | 207 | 140 | 7 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 5.13e-04 | 208 | 140 | 7 | GO:0097014 | |
| GeneOntologyCellularComponent | myofibril | 5.17e-04 | 273 | 140 | 8 | GO:0030016 | |
| GeneOntologyCellularComponent | Z disc | 5.45e-04 | 151 | 140 | 6 | GO:0030018 | |
| GeneOntologyCellularComponent | striated muscle thin filament | 7.64e-04 | 27 | 140 | 3 | GO:0005865 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 7.66e-04 | 290 | 140 | 8 | GO:0043292 | |
| GeneOntologyCellularComponent | I band | 8.95e-04 | 166 | 140 | 6 | GO:0031674 | |
| GeneOntologyCellularComponent | basal cortex | 9.15e-04 | 7 | 140 | 2 | GO:0045180 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | TPM1 TPM2 CFAP276 DCDC1 EFCAB6 CEP162 CHMP5 DNAH1 DES TTLL6 PAK1 KIF14 CDK5RAP2 MARK2 GOLGA2 | 1.04e-03 | 899 | 140 | 15 | GO:0099513 |
| GeneOntologyCellularComponent | myofilament | 1.26e-03 | 32 | 140 | 3 | GO:0036379 | |
| GeneOntologyCellularComponent | spindle | DCDC1 CEP162 CHMP5 DLGAP5 HMMR ALPK1 PKD2 KIF14 CDK5RAP2 GOLGA2 | 1.30e-03 | 471 | 140 | 10 | GO:0005819 |
| GeneOntologyCellularComponent | nuclear envelope | PSEN1 UACA PRICKLE1 CHMP5 BCHE RGS7 DES CLCA2 SYNE2 NUP133 PAK1 | 1.40e-03 | 560 | 140 | 11 | GO:0005635 |
| GeneOntologyCellularComponent | replication fork | 1.79e-03 | 77 | 140 | 4 | GO:0005657 | |
| GeneOntologyCellularComponent | condensed chromosome, centromeric region | 1.93e-03 | 193 | 140 | 6 | GO:0000779 | |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 8.29e-05 | 35 | 94 | 4 | MM15005 | |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 9.27e-05 | 36 | 94 | 4 | M18647 | |
| Pathway | WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY | 1.15e-04 | 38 | 94 | 4 | M39549 | |
| Pubmed | TPM1 TRPM6 ATRX CEP162 DLGAP5 MPEG1 ZNF318 FCHO2 ZRANB3 SLFN12L RESF1 TLE4 CCSER2 MKLN1 SNX27 CDK5RAP2 ATP11A ADAM17 ANKRD12 CCDC171 | 2.47e-08 | 1084 | 144 | 20 | 11544199 | |
| Pubmed | 9.95e-08 | 54 | 144 | 6 | 22266860 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | DSC3 UACA CHMP5 SCEL NHSL1 PTPRJ CCSER2 ARHGAP29 N4BP1 ADAM17 MARK2 GOLGA5 GOLGA2 TPD52L2 | 1.08e-07 | 565 | 144 | 14 | 25468996 |
| Pubmed | Nebulin interactions with actin and tropomyosin are altered by disease-causing mutations. | 6.91e-07 | 5 | 144 | 3 | 25110572 | |
| Pubmed | 1.12e-06 | 251 | 144 | 9 | 29778605 | ||
| Pubmed | Disruption of striated preferentially expressed gene locus leads to dilated cardiomyopathy in mice. | 2.40e-06 | 7 | 144 | 3 | 19118250 | |
| Pubmed | 2.88e-06 | 210 | 144 | 8 | 16565220 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | TPM1 FKBP15 WASHC4 PSEN1 UACA ZNF318 SMOC1 IBTK MDN1 GCC2 SLC39A6 CDK5RAP2 MARK2 GOLGA2 | 3.30e-06 | 754 | 144 | 14 | 33060197 |
| Pubmed | CASP8AP2 DSC3 ATRX UACA RPAP3 HMMR PRPF8 BLM GUF1 MTX2 MDN1 N4BP2 SYNE2 CCSER2 NUP133 SLC39A6 CDK5RAP2 MARK2 GOLGA5 TPD52L2 | 3.54e-06 | 1487 | 144 | 20 | 33957083 | |
| Pubmed | DSC3 RPAP3 CEP162 FCHO2 BLM NHSL1 PTPRJ SYNE2 NUP133 SNX27 KIF14 SLC39A6 CDK5RAP2 GOLGA5 KNL1 TPD52L2 | 7.81e-06 | 1049 | 144 | 16 | 27880917 | |
| Pubmed | TPM1 TPM2 PTBP3 CCDC185 ATRX CCDC150 ZNF318 NEB PRPF8 LYST DES MDN1 N4BP2 SYNE2 ATP11A TAF4 POLQ KIAA2012 NIPBL | 8.50e-06 | 1442 | 144 | 19 | 35575683 | |
| Pubmed | CASP8AP2 RPAP3 ZNF318 RESF1 N4BP2 GCC2 TLE4 KIF14 GOLGA5 KNL1 | 1.04e-05 | 418 | 144 | 10 | 34709266 | |
| Pubmed | Molecular diversity of myofibrillar proteins: gene regulation and functional significance. | 1.49e-05 | 12 | 144 | 3 | 8618961 | |
| Pubmed | 1.49e-05 | 12 | 144 | 3 | 8424456 | ||
| Pubmed | 1.49e-05 | 263 | 144 | 8 | 34702444 | ||
| Pubmed | Isolation and characterization of a cDNA that encodes mouse fibroblast tropomyosin isoform 2. | 1.70e-05 | 2 | 144 | 2 | 3244365 | |
| Pubmed | Changes in end-to-end interactions of tropomyosin affect mouse cardiac muscle dynamics. | 1.70e-05 | 2 | 144 | 2 | 16501024 | |
| Pubmed | The IL-1 receptor accessory protein is essential for PI 3-kinase recruitment and activation. | 1.70e-05 | 2 | 144 | 2 | 15044087 | |
| Pubmed | Rescue of tropomyosin-induced familial hypertrophic cardiomyopathy mice by transgenesis. | 1.70e-05 | 2 | 144 | 2 | 17416600 | |
| Pubmed | Renaturation of skeletal muscle tropomyosin: implications for in vivo assembly. | 1.70e-05 | 2 | 144 | 2 | 3857586 | |
| Pubmed | Molecular dissection of the interaction of desmin with the C-terminal region of nebulin. | 1.70e-05 | 2 | 144 | 2 | 12064939 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 23205574 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 23615443 | ||
| Pubmed | FGF2 antagonizes aberrant TGFβ regulation of tropomyosin: role for posterior capsule opacity. | 1.70e-05 | 2 | 144 | 2 | 27976512 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 30545627 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 8760295 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 15003449 | ||
| Pubmed | Mannosidase 2, alpha 1 deficiency is associated with ricin resistance in embryonic stem (ES) cells. | 1.70e-05 | 2 | 144 | 2 | 21886775 | |
| Pubmed | Polycystin-2 associates with tropomyosin-1, an actin microfilament component. | 1.70e-05 | 2 | 144 | 2 | 12527301 | |
| Pubmed | Developmental analysis of tropomyosin gene expression in embryonic stem cells and mouse embryos. | 1.70e-05 | 2 | 144 | 2 | 7684495 | |
| Pubmed | 2.55e-05 | 370 | 144 | 9 | 15164053 | ||
| Pubmed | A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. | 3.63e-05 | 298 | 144 | 8 | 32353859 | |
| Pubmed | 3.74e-05 | 16 | 144 | 3 | 25987543 | ||
| Pubmed | 4.12e-05 | 222 | 144 | 7 | 37071664 | ||
| Pubmed | 4.52e-05 | 497 | 144 | 10 | 23414517 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 4.52e-05 | 497 | 144 | 10 | 36774506 | |
| Pubmed | 5.00e-05 | 503 | 144 | 10 | 16964243 | ||
| Pubmed | PIGEA-14, a novel coiled-coil protein affecting the intracellular distribution of polycystin-2. | 5.09e-05 | 3 | 144 | 2 | 15194699 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 22356911 | ||
| Pubmed | Dissociated presenilin-1 and TACE processing of ErbB4 in lung alveolar type II cell differentiation. | 5.09e-05 | 3 | 144 | 2 | 24462774 | |
| Pubmed | Protein kinase activity of phosphoinositide 3-kinase regulates beta-adrenergic receptor endocytosis. | 5.09e-05 | 3 | 144 | 2 | 16094730 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 27020427 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 11356630 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 7568216 | ||
| Pubmed | Identification of risk loci for Crohn's disease phenotypes using a genome-wide association study. | 5.09e-05 | 3 | 144 | 2 | 25557950 | |
| Pubmed | BLM helicase stimulates the ATPase and chromatin-remodeling activities of RAD54. | 5.09e-05 | 3 | 144 | 2 | 19671661 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 9400381 | ||
| Pubmed | Silencing of the Tropomyosin-1 gene by DNA methylation alters tumor suppressor function of TGF-beta. | 5.09e-05 | 3 | 144 | 2 | 15897890 | |
| Pubmed | Vertebrate tropomyosin: distribution, properties and function. | 5.09e-05 | 3 | 144 | 2 | 11563548 | |
| Pubmed | 6.23e-05 | 100 | 144 | 5 | 26073538 | ||
| Pubmed | 6.42e-05 | 19 | 144 | 3 | 9070936 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TPM1 EXPH5 CEP162 ALPK1 LYST NHSL1 MDN1 RESF1 N4BP2 SYNE2 CCSER2 KIF14 MARK2 | 6.42e-05 | 861 | 144 | 13 | 36931259 |
| Pubmed | 6.91e-05 | 421 | 144 | 9 | 36976175 | ||
| Pubmed | 7.17e-05 | 103 | 144 | 5 | 10574462 | ||
| Pubmed | FAT4 PRICKLE1 DLGAP5 RFC1 NEB MDN1 GCC2 SYNE2 CDK5RAP2 NIPBL KNL1 | 7.52e-05 | 638 | 144 | 11 | 31182584 | |
| Pubmed | 7.72e-05 | 169 | 144 | 6 | 31462741 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | TPM1 WASHC4 UACA HMMR PRPF8 BLM ZFP1 CCSER2 NUP133 KIF14 CDK5RAP2 MARK2 NIPBL GOLGA2 KNL1 | 9.46e-05 | 1155 | 144 | 15 | 20360068 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.01e-04 | 256 | 144 | 7 | 33397691 | |
| Pubmed | 1.02e-04 | 4 | 144 | 2 | 23955714 | ||
| Pubmed | Ca2+-dependent interaction of S100A2 with muscle and nonmuscle tropomyosins. | 1.02e-04 | 4 | 144 | 2 | 9092943 | |
| Pubmed | 1.02e-04 | 4 | 144 | 2 | 17488291 | ||
| Pubmed | Degradation of cytoskeletal proteins by the human immunodeficiency virus type 1 protease. | 1.02e-04 | 4 | 144 | 2 | 1516138 | |
| Pubmed | Tropomyosin isoforms localize to distinct microfilament populations in osteoclasts. | 1.02e-04 | 4 | 144 | 2 | 16765662 | |
| Pubmed | 1.02e-04 | 4 | 144 | 2 | 35420656 | ||
| Pubmed | Chromosome mapping of nine tropomyosin-related sequences in mice. | 1.02e-04 | 4 | 144 | 2 | 7613033 | |
| Pubmed | Neuronal adaptor FE65 stimulates Rac1-mediated neurite outgrowth by recruiting and activating ELMO1. | 1.02e-04 | 4 | 144 | 2 | 29615491 | |
| Pubmed | A systematic nomenclature for mammalian tropomyosin isoforms. | 1.02e-04 | 4 | 144 | 2 | 25369766 | |
| Pubmed | 1.02e-04 | 4 | 144 | 2 | 9108196 | ||
| Pubmed | 1.02e-04 | 4 | 144 | 2 | 8661144 | ||
| Pubmed | 1.02e-04 | 111 | 144 | 5 | 12508121 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | FKBP15 WASHC4 ATRX UACA HMMR LYST NUP133 SNX27 CDK5RAP2 NKTR MARK2 GOLGA2 KNL1 | 1.11e-04 | 910 | 144 | 13 | 36736316 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | FKBP15 ATRX RPAP3 CCDC150 HMMR PRPF8 BLM XPO5 GCC2 PKD2 MKLN1 NUP133 SNX27 NKTR MARK2 GOLGA5 | 1.23e-04 | 1321 | 144 | 16 | 27173435 |
| Pubmed | 1.36e-04 | 118 | 144 | 5 | 30979931 | ||
| Pubmed | HMMR RALGAPA2 PKHD1L1 RGS7 ELMO1 FETUB IBTK SHF GCC2 PAK1 KCNH5 | 1.42e-04 | 686 | 144 | 11 | 29987050 | |
| Pubmed | 1.64e-04 | 472 | 144 | 9 | 38943005 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 1.65e-04 | 582 | 144 | 10 | 20467437 | |
| Pubmed | 1.69e-04 | 5 | 144 | 2 | 9016781 | ||
| Pubmed | 1.69e-04 | 5 | 144 | 2 | 26567335 | ||
| Pubmed | 1.69e-04 | 5 | 144 | 2 | 15534001 | ||
| Pubmed | 1.69e-04 | 5 | 144 | 2 | 11901144 | ||
| Pubmed | 1.69e-04 | 5 | 144 | 2 | 11717310 | ||
| Pubmed | The NYN domains: novel predicted RNAses with a PIN domain-like fold. | 1.69e-04 | 5 | 144 | 2 | 17114934 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | CASP8AP2 ATRX ZNF318 CNTLN BLM RESF1 N4BP2 KIF14 GOLGA2 KNL1 | 1.79e-04 | 588 | 144 | 10 | 38580884 |
| Pubmed | 1.89e-04 | 27 | 144 | 3 | 16460286 | ||
| Pubmed | FKBP15 UACA DLGAP5 ZNF318 MDN1 N4BP2 SYNE2 PAK1 CDK5RAP2 TAF4 NIPBL GOLGA2 TPD52L2 | 1.94e-04 | 963 | 144 | 13 | 28671696 | |
| Pubmed | 2.07e-04 | 129 | 144 | 5 | 23022380 | ||
| Pubmed | Novel interactors and a role for supervillin in early cytokinesis. | 2.11e-04 | 28 | 144 | 3 | 20309963 | |
| Pubmed | 2.53e-04 | 6 | 144 | 2 | 22666460 | ||
| Pubmed | 2.53e-04 | 6 | 144 | 2 | 22908310 | ||
| Pubmed | The ulcerative colitis marker protein WAFL interacts with accessory proteins in endocytosis. | 2.53e-04 | 6 | 144 | 2 | 20376207 | |
| Pubmed | 2.53e-04 | 6 | 144 | 2 | 10929709 | ||
| Pubmed | 2.53e-04 | 6 | 144 | 2 | 23792823 | ||
| Pubmed | Alpha-kinases: a new class of protein kinases with a novel catalytic domain. | 2.53e-04 | 6 | 144 | 2 | 10021370 | |
| Pubmed | 2.53e-04 | 6 | 144 | 2 | 9160885 | ||
| Pubmed | 3.16e-04 | 32 | 144 | 3 | 20301486 | ||
| Pubmed | 3.46e-04 | 33 | 144 | 3 | 19834762 | ||
| Pubmed | Abnormal blood vessel development in mice lacking presenilin-1. | 3.53e-04 | 7 | 144 | 2 | 12834865 | |
| Pubmed | KLHL41 stabilizes skeletal muscle sarcomeres by nonproteolytic ubiquitination. | 3.53e-04 | 7 | 144 | 2 | 28826497 | |
| Pubmed | 3.53e-04 | 7 | 144 | 2 | 16059920 | ||
| Pubmed | 3.53e-04 | 7 | 144 | 2 | 10833443 | ||
| Interaction | NDC80 interactions | UACA CEP162 HMMR CNTLN NHSL1 XPO5 GCC2 SYNE2 KIF14 CDK5RAP2 GOLGA2 KNL1 | 1.64e-06 | 312 | 138 | 12 | int:NDC80 |
| GeneFamily | Tropomyosins | 1.40e-04 | 4 | 88 | 2 | 777 | |
| GeneFamily | Transient receptor potential cation channels | 3.34e-04 | 28 | 88 | 3 | 249 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 1.96e-03 | 51 | 88 | 3 | 870 | |
| GeneFamily | X-linked mental retardation|Angiotensin receptors | 2.19e-03 | 53 | 88 | 3 | 103 | |
| GeneFamily | ATPase phospholipid transporting | 2.36e-03 | 15 | 88 | 2 | 1210 | |
| GeneFamily | Cadherin related | 3.04e-03 | 17 | 88 | 2 | 24 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ATRN MAN2A1 WASHC4 ATRX DLGAP5 HMMR RGS7 BLM IBTK MTX2 MDN1 GCC2 TLE4 SYNE2 CCSER2 PKD2 MKLN1 NUP133 ARHGAP29 KIF14 N4BP1 ADAM17 TAF4 NIPBL | 3.81e-11 | 856 | 142 | 24 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | MAN2A1 WASHC4 ATRX RGS7 BLM IBTK MTX2 MDN1 TLE4 CCSER2 PKD2 MKLN1 ARHGAP29 KIF14 TAF4 | 3.90e-08 | 466 | 142 | 15 | M13522 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CASP8AP2 RPAP3 DLGAP5 HMMR RFC1 BLM RESF1 GCC2 SYNE2 ETAA1 KIF14 SLC39A6 CDK5RAP2 NKTR POLQ NIPBL KNL1 | 1.07e-07 | 656 | 142 | 17 | M18979 |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_VS_INH_PRETREAT_AND_ACT_WITH_TCELL_MEMBRANES_MAST_CELL_UP | 1.53e-06 | 200 | 142 | 9 | M7342 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | PTBP3 PSEN1 HBP1 EZH1 LYST IBTK RESF1 TGDS CCSER2 MKLN1 N4BP1 ADAM17 ANKRD12 GOLGA5 NIPBL GOLGA2 | 1.04e-05 | 822 | 142 | 16 | M6782 |
| Coexpression | ZHONG_PFC_C1_OPC | 4.85e-05 | 238 | 142 | 8 | M39096 | |
| Coexpression | FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN | 8.21e-05 | 190 | 142 | 7 | M761 | |
| Coexpression | GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION | 8.65e-05 | 43 | 142 | 4 | MM926 | |
| Coexpression | GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION | 8.65e-05 | 43 | 142 | 4 | M2370 | |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | FKBP15 UACA PRICKLE1 RPAP3 DLGAP5 HMMR BLM NHSL1 N4BP2 ZFP1 ARHGAP29 KIF14 ZC3H12C POLQ KNL1 | 1.04e-04 | 892 | 142 | 15 | M18120 |
| Coexpression | GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN | 1.06e-04 | 198 | 142 | 7 | M8624 | |
| Coexpression | GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_UP | 1.06e-04 | 198 | 142 | 7 | M9035 | |
| Coexpression | GSE6875_TCONV_VS_TREG_UP | 1.06e-04 | 198 | 142 | 7 | M6799 | |
| Coexpression | GSE14308_TH1_VS_INDUCED_TREG_UP | 1.13e-04 | 200 | 142 | 7 | M3378 | |
| Coexpression | GSE30083_SP1_VS_SP4_THYMOCYTE_DN | 1.13e-04 | 200 | 142 | 7 | M5030 | |
| Coexpression | GSE30083_SP3_VS_SP4_THYMOCYTE_DN | 1.13e-04 | 200 | 142 | 7 | M5037 | |
| Coexpression | GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_LPS_STIM_UP | 1.13e-04 | 200 | 142 | 7 | M6352 | |
| Coexpression | GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_UP | 1.13e-04 | 200 | 142 | 7 | M5185 | |
| Coexpression | GSE22919_RESTING_VS_IL2_IL12_IL15_STIM_NK_CELL_DN | 1.13e-04 | 200 | 142 | 7 | M7836 | |
| Coexpression | GSE40666_WT_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN | 1.13e-04 | 200 | 142 | 7 | M9217 | |
| Coexpression | DESCARTES_FETAL_CEREBRUM_ASTROCYTES | 1.36e-04 | 206 | 142 | 7 | M40171 | |
| Coexpression | MARSON_BOUND_BY_E2F4_UNSTIMULATED | CASP8AP2 FKBP15 ATRX DLGAP5 CCDC150 CFAP43 HMMR BLM ETAA1 NUP133 CDK5RAP2 POLQ KNL1 | 1.42e-04 | 714 | 142 | 13 | M1744 |
| Coexpression | DESCARTES_FETAL_LUNG_CILIATED_EPITHELIAL_CELLS | CFAP251 CFAP276 DCDC1 EFCAB6 RSPH4A FAM81B CFAP43 DNAH1 TTLL6 KIAA2012 MAP3K19 | 1.80e-04 | 540 | 142 | 11 | M40241 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | CASP8AP2 ATRX RPAP3 CEP162 BLM GCC2 SYNE2 POLQ NIPBL KNL1 MAP3K19 | 7.07e-06 | 311 | 140 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | BM Top 100 - skeletal muscle | 1.02e-05 | 75 | 140 | 6 | BM Top 100 - skeletal muscle | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | ATRX NEXMIF HBP1 TEX15 RFC1 NEB EZH1 FETUB SYCP2 RESF1 CLCA2 PTPRJ SYNE2 ARHGAP29 UNC13C NKTR ANKRD12 | 1.31e-05 | 770 | 140 | 17 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 4.17e-05 | 192 | 140 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_500 | ATRX NEXMIF TEX15 NEB FETUB SYCP2 RESF1 SYNE2 ARHGAP29 UNC13C ANKRD12 | 4.40e-05 | 379 | 140 | 11 | gudmap_developingGonad_P2_ovary_500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | WASHC4 ATRX NEXMIF ZNF318 TEX15 RFC1 NEB EZH1 SYCP2 RESF1 SYNE2 ARHGAP29 SNX27 N4BP1 NKTR ANKRD12 | 5.60e-05 | 778 | 140 | 16 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | kidney_e10.5_UretericTip_HoxB7_top-relative-expression-ranked_1000 | PTBP3 DLGAP5 HMMR ZRANB3 BRWD3 BLM NHSL1 MTX2 ETAA1 PAK1 KIF14 ZC3H12C LY75 POLQ KNL1 KCNH5 | 6.42e-05 | 787 | 140 | 16 | gudmap_kidney_e10.5_UretericTip_HoxB7_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | RPAP3 CCDC150 ZNF318 HMMR TEX15 SMOC1 ZRANB3 BLM SYCP2 MDN1 NUP133 PAK1 SNX27 KIF14 ANKRD12 CCDC171 | 8.98e-05 | 810 | 140 | 16 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | CASP8AP2 CCDC150 ZNF318 TEX15 RALGAPA2 LYST ZRANB3 BLM SYCP2 MDN1 NUP133 PAK1 SNX27 KIF14 ANKRD12 CCDC171 | 1.04e-04 | 820 | 140 | 16 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | kidney_e10.5_UretericTip_HoxB7_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.07e-04 | 348 | 140 | 10 | gudmap_kidney_e10.5_UretericTip_HoxB7_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#3_top-relative-expression-ranked_500 | 1.77e-04 | 79 | 140 | 5 | gudmap_developingGonad_P2_ovary_500_k3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | CASP8AP2 ATRX CEP162 NEXMIF MPEG1 HMMR CNTLN IL18R1 BLM GCC2 TLE4 SYNE2 PAK1 KIF14 ZC3H12C NIPBL GOLGA2 KNL1 | 2.15e-04 | 1060 | 140 | 18 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500 | ATRX NEXMIF ZNF318 TEX15 SYCP2 RESF1 SYNE2 ARHGAP29 SNX27 ANKRD12 | 2.28e-04 | 382 | 140 | 10 | gudmap_developingGonad_e14.5_ ovary_500 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_200 | 2.45e-04 | 132 | 140 | 6 | gudmap_developingGonad_P2_ovary_200 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | ATRX NEXMIF ZNF318 TEX15 NEB SYCP2 RESF1 SYNE2 ARHGAP29 ANKRD12 | 2.53e-04 | 387 | 140 | 10 | gudmap_developingGonad_e18.5_ovary_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | CASP8AP2 ATRX CEP162 ATP8A2 BCHE HMMR RFC1 RALGAPA2 IL18R1 BRWD3 GCC2 TLE4 SYNE2 ETAA1 PAK1 KIF14 SLC39A6 ZC3H12C NIPBL KNL1 KCNH5 | 2.53e-04 | 1370 | 140 | 21 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Bone marrow, avg-2 | 2.58e-04 | 388 | 140 | 10 | GSM538352_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_500 | CCDC150 TEX15 SMOC1 ZRANB3 BLM SYCP2 MDN1 PAK1 KIF14 CCDC171 | 3.03e-04 | 396 | 140 | 10 | gudmap_dev gonad_e13.5_M_GermCell_Oct_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#5_top-relative-expression-ranked_500 | 3.42e-04 | 91 | 140 | 5 | gudmap_developingGonad_e14.5_ ovary_500_k5 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.73e-04 | 333 | 140 | 9 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000 | |
| CoexpressionAtlas | fallopian tube | CFAP251 CFAP276 DCDC1 EFCAB6 RSPH4A FAM81B CFAP43 PKHD1L1 KIAA2012 MAP3K19 | 3.84e-04 | 408 | 140 | 10 | fallopian tube |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | CASP8AP2 ATRX CEP162 NEXMIF ATP8A2 MPEG1 HMMR CNTLN IL18R1 BLM GCC2 TLE4 SYNE2 PAK1 KIF14 SNX31 ZC3H12C NIPBL GOLGA2 KNL1 KCNH5 | 3.86e-04 | 1414 | 140 | 21 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-08 | 187 | 144 | 9 | 14c239af77116d28d511dea754b6150d20488080 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | CFAP251 CFAP276 DCDC1 RSPH4A FAM81B CFAP43 BCO2 KIAA2012 MAP3K19 | 1.23e-08 | 190 | 144 | 9 | a90a38fccdbf75a286b4d258fc54920c02b282f7 |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.29e-08 | 191 | 144 | 9 | 912e2d10d3423aa7f708fcf2b11da1845f12d7d3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.29e-08 | 191 | 144 | 9 | 77a2746b6d9c53b08d4405411c16fcc5a6c734ce | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.76e-08 | 198 | 144 | 9 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.92e-08 | 200 | 144 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | CFAP251 CFAP276 DCDC1 RSPH4A FAM81B CFAP43 DNAH1 KIAA2012 MAP3K19 | 1.92e-08 | 200 | 144 | 9 | 31d75c26055177d656df1fbb10b764cebd61e122 |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | CFAP251 CFAP276 DCDC1 RSPH4A FAM81B CFAP43 DNAH1 KIAA2012 MAP3K19 | 1.92e-08 | 200 | 144 | 9 | e1dce91c6c531bb212002a14705e496d77ad3490 |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.42e-08 | 151 | 144 | 8 | 81cf939ed4df9574fbfff265e109cb9f947d7e6e | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.42e-08 | 151 | 144 | 8 | 9cbcbbc22965a9f0be8364e733d205dd64f2a533 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-07 | 178 | 144 | 8 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-07 | 182 | 144 | 8 | 21dcab170ffeef89faa9fee5008568cb6e15c694 | |
| ToppCell | Ciliated_cells-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.64e-07 | 185 | 144 | 8 | 4fc7113d3dadc716ec5a8e62b58543cc00ce5b16 | |
| ToppCell | Ciliated_cells-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.64e-07 | 185 | 144 | 8 | d77ca57b02125a3a57a37f4aed20c89803b7d551 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-07 | 185 | 144 | 8 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.64e-07 | 185 | 144 | 8 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-07 | 187 | 144 | 8 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-07 | 126 | 144 | 7 | 8ae631694bbba40f64e55e2be8162d7a40eeadc5 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.85e-07 | 188 | 144 | 8 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.93e-07 | 189 | 144 | 8 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.93e-07 | 189 | 144 | 8 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.93e-07 | 189 | 144 | 8 | dc440015949a768188c67661b6be63b1ead1a0f0 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.93e-07 | 189 | 144 | 8 | a3cd4c2da4feb9bdcd8957f3e344d095da1367b8 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 1.93e-07 | 189 | 144 | 8 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.93e-07 | 189 | 144 | 8 | 93b1026bb1ba759e5704561c9a5de14a30c08894 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.01e-07 | 190 | 144 | 8 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.01e-07 | 190 | 144 | 8 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.01e-07 | 190 | 144 | 8 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.09e-07 | 191 | 144 | 8 | 2a8e6d560907e71e9f6e190ca0667da804e25641 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.09e-07 | 191 | 144 | 8 | 46c9d4d10c66c0fae1fa351924091b69ea2f38d4 | |
| ToppCell | Mild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.09e-07 | 191 | 144 | 8 | 995e76bbf07674d95b8ef09e078cf6410af27a09 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.09e-07 | 191 | 144 | 8 | a37f20172b85566b9039254a89680e37fd503fd5 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.09e-07 | 191 | 144 | 8 | 2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.09e-07 | 191 | 144 | 8 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.09e-07 | 191 | 144 | 8 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.09e-07 | 191 | 144 | 8 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.18e-07 | 192 | 144 | 8 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | Bronchial_Brush|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.27e-07 | 193 | 144 | 8 | 3e693ac4c92576e3f2c9efdd3f1d96d3d336e260 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.27e-07 | 193 | 144 | 8 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 2.27e-07 | 193 | 144 | 8 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.36e-07 | 194 | 144 | 8 | b4ce60c06568123008b1081d644733cb91c28f51 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.36e-07 | 194 | 144 | 8 | 7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.36e-07 | 194 | 144 | 8 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.36e-07 | 194 | 144 | 8 | a46238514bca920c3e3713d23c18ba24a09e2a29 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 2.36e-07 | 194 | 144 | 8 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.45e-07 | 195 | 144 | 8 | 649fd2336e963f6a150d182a53ad5dd838ca80b1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.45e-07 | 195 | 144 | 8 | 0e763f36786515698b593e5c93f6a56619c1242d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.45e-07 | 195 | 144 | 8 | 581b04220587e1d5198b1abd6965965ace7803e7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.45e-07 | 195 | 144 | 8 | 93b1559382a12cfb158aa5fac7386e38b4f87989 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 2.45e-07 | 195 | 144 | 8 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.45e-07 | 195 | 144 | 8 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.45e-07 | 195 | 144 | 8 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.45e-07 | 195 | 144 | 8 | 129ad5f4253ecb1a8477cc38773e6e91ea9570b0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.45e-07 | 195 | 144 | 8 | 3e70ee987d66d450062d5df3d7c733ccc7344470 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.45e-07 | 195 | 144 | 8 | 9651ee03738226ee10e901f8b9ec6a417eb9c301 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.55e-07 | 196 | 144 | 8 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.55e-07 | 196 | 144 | 8 | 686a5a0ddb00929842c1c98445c59edfcc9a8a04 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.55e-07 | 196 | 144 | 8 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.55e-07 | 196 | 144 | 8 | 67aefc480714e4b8c9ae53c036efdc07ec6f94af | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.55e-07 | 196 | 144 | 8 | ca56311edc6788e032e7635fa69b1e07035202b5 | |
| ToppCell | Severe_COVID-19-Epithelial-Ciliated|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.55e-07 | 196 | 144 | 8 | 1cdef976a754c90d18b6149d367bd64e6e99b0a9 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.55e-07 | 196 | 144 | 8 | 69f5081e06d84ec1d9695762df801a9d0df1984b | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 2.65e-07 | 197 | 144 | 8 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.65e-07 | 197 | 144 | 8 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 2.65e-07 | 197 | 144 | 8 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.75e-07 | 198 | 144 | 8 | f088badb90c6c2d916195f5649eda102119c9ac6 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 2.86e-07 | 199 | 144 | 8 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | distal-Epithelial-Ciliated-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.86e-07 | 199 | 144 | 8 | 2de1fe124737a6cca4b3805ab3056f9d9d7c16c7 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.86e-07 | 199 | 144 | 8 | 2498237b9e895ca4826a3378d9d40989968df72b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.86e-07 | 199 | 144 | 8 | 542ec45c931b40738df1f3777b00c83be33a514a | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 2.86e-07 | 199 | 144 | 8 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.86e-07 | 199 | 144 | 8 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 2.86e-07 | 199 | 144 | 8 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.97e-07 | 200 | 144 | 8 | 52aef65f01b06cd98056f17977efe525aee6eb6f | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.97e-07 | 200 | 144 | 8 | 0d9b8d51a7630e70e60c76c763ff82df4c559152 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.97e-07 | 200 | 144 | 8 | 55c148238d5c80c1faa3428a917ae8075be2c145 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.97e-07 | 200 | 144 | 8 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.97e-07 | 200 | 144 | 8 | 85c98da55f7cd4ffdf9d309b56c8cc5d43f3c04c | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.97e-07 | 200 | 144 | 8 | 0675f580ccef705875854247bbfd4ee2bcf126a1 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.97e-07 | 200 | 144 | 8 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.97e-07 | 200 | 144 | 8 | 12bc7d95c4166d12487081a76d210b7abe5991b0 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.12e-07 | 154 | 144 | 7 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.12e-07 | 154 | 144 | 7 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.12e-07 | 154 | 144 | 7 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.12e-07 | 154 | 144 | 7 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.44e-07 | 155 | 144 | 7 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.44e-07 | 155 | 144 | 7 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | normal-na-Lymphocytic_T-T4_reg-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.04e-06 | 163 | 144 | 7 | 43887e7687fc6367efac0c1f56a9534b06f47b7f | |
| ToppCell | Dividing_Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.18e-06 | 166 | 144 | 7 | c503036f3c19ef186e1e62c9643c49dea3827f51 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-06 | 166 | 144 | 7 | 2642544070564debe2deb2938d2c33997bf5ef02 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-06 | 167 | 144 | 7 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-06 | 168 | 144 | 7 | d35944fd9fea9934ce1e76b2b35d48e2300cca61 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-06 | 171 | 144 | 7 | 55c7bf7211587fa08df13c0a4ff5b78a85d5439e | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.44e-06 | 171 | 144 | 7 | 6a5ac0f56bd7b4543be103100fb735ca6bc5b8bf | |
| ToppCell | Ciliated_cells-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.49e-06 | 172 | 144 | 7 | 187ae91148d293537afc77e10da2b64302322224 | |
| ToppCell | TCGA-Head_and_Esophagus-Solid_Tissue_Normal-Head_and_Neck-Head_and_Neck_normal_tissue-5|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.49e-06 | 172 | 144 | 7 | 6b8a8d3b97c10b9d092307eed3cacbd2745df185 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.55e-06 | 173 | 144 | 7 | efb8072475000888efe088d00e870c56ffad4172 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.61e-06 | 174 | 144 | 7 | 94575a605c725de83f66a6cf7df9d7bb360ffc56 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.61e-06 | 174 | 144 | 7 | 40c81ab36d7931e271e20d7d56fed32463c75f41 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.61e-06 | 174 | 144 | 7 | 65147b0f8c2ccadd5685430d31081520c157536a | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.79e-05 | 49 | 79 | 5 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.09e-05 | 50 | 79 | 5 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_UNASSIGNED_1 | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | 2.57e-06 | 191 | 138 | 9 | 4168_DN | |
| Drug | AC1L1B35 | 5.87e-06 | 74 | 138 | 6 | CID000001263 | |
| Drug | eddp | 7.49e-06 | 7 | 138 | 3 | CID000028292 | |
| Disease | Familial dilated cardiomyopathy | 5.38e-05 | 44 | 138 | 4 | C0340427 | |
| Disease | Autosomal Recessive Primary Microcephaly | 1.44e-04 | 22 | 138 | 3 | C3711387 | |
| Disease | Nemaline Myopathy, Childhood Onset | 4.49e-04 | 7 | 138 | 2 | C0546125 | |
| Disease | Malignant neoplasm of breast | DSC3 BCHE ZNF318 HMMR DES CLCA2 UNC45B N4BP2 SYNE2 NUP133 PAK1 ARHGAP29 SLC39A6 NIPBL | 5.26e-04 | 1074 | 138 | 14 | C0006142 |
| Disease | Primary dilated cardiomyopathy | 5.39e-04 | 34 | 138 | 3 | cv:C0007193 | |
| Disease | Myopathies, Nemaline | 5.97e-04 | 8 | 138 | 2 | C0206157 | |
| Disease | Nemaline myopathy | 5.97e-04 | 8 | 138 | 2 | cv:C0206157 | |
| Disease | Todd Paralysis | 7.65e-04 | 9 | 138 | 2 | C0234544 | |
| Disease | Paralysed | 7.65e-04 | 9 | 138 | 2 | C0522224 | |
| Disease | Squamous cell carcinoma of esophagus | 1.05e-03 | 95 | 138 | 4 | C0279626 | |
| Disease | Congenital myopathy (disorder) | 1.39e-03 | 12 | 138 | 2 | C0270960 | |
| Disease | Cardiomyopathy | 1.40e-03 | 47 | 138 | 3 | cv:C0878544 | |
| Disease | obsolete_red blood cell distribution width | TPM1 CFAP251 PSEN1 FCHO2 RFC1 SMOC1 SLFN12L RESF1 ST8SIA6 CLIC2 SYNE2 SNX31 ATP11A ANKRD12 KNL1 | 1.63e-03 | 1347 | 138 | 15 | EFO_0005192 |
| Disease | endometrial carcinoma | 1.99e-03 | 113 | 138 | 4 | EFO_1001512 | |
| Disease | Autosomal recessive primary microcephaly | 2.19e-03 | 15 | 138 | 2 | cv:C3711387 | |
| Disease | idiopathic pulmonary fibrosis | 2.44e-03 | 57 | 138 | 3 | EFO_0000768 | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 2.50e-03 | 16 | 138 | 2 | DOID:0070296 (is_implicated_in) | |
| Disease | level of Sphingomyelin (d32:1) in blood serum | 2.82e-03 | 17 | 138 | 2 | OBA_2045173 | |
| Disease | acute lymphoblastic leukemia, response to antineoplastic agent | 3.52e-03 | 19 | 138 | 2 | EFO_0000220, GO_0097327 | |
| Disease | magnesium measurement | 3.69e-03 | 66 | 138 | 3 | EFO_0004845 | |
| Disease | platelet measurement | 3.74e-03 | 315 | 138 | 6 | EFO_0005036 | |
| Disease | cup-to-disc ratio measurement | 4.21e-03 | 430 | 138 | 7 | EFO_0006939 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QKKVQDTNLSSLINY | 416 | Q8N715 | |
| YKSLQAEETNQQSSK | 956 | Q8NEM8 | |
| KNQFNDYTSKKESCV | 586 | P06276 | |
| NNYLTRKQHEKSQTS | 1246 | Q8NDM7 | |
| SSNFYITEKNRNEIK | 56 | Q92556 | |
| REKYKNITAQKSSSN | 966 | Q9NXG0 | |
| KTNETEKAFQTSQQK | 126 | Q6TFL3 | |
| SITQALQKSKENYNA | 131 | Q0JRZ9 | |
| ETQSLYKLNITAKDQ | 1381 | Q6V0I7 | |
| SNEKSKVKSQIYFTD | 361 | A6NC57 | |
| QIFNNSKAYTSNKKS | 1396 | Q6RI45 | |
| ASNSKYVSADRNLIK | 1376 | Q6UB98 | |
| LQSDTYKANSAKNRI | 126 | Q9BYV7 | |
| LEKTSKQNAQYSNSQ | 1166 | Q9UKL3 | |
| NKFRDNQISTAKYSV | 66 | Q9NTI2 | |
| LSNNTKVVKTEYKAT | 1141 | Q96QP1 | |
| NNKELVSNSKTRAIY | 406 | Q8TBY9 | |
| NQKTTQDTYRTKIQF | 96 | Q5T5A4 | |
| ESINTSNETEYLKQK | 1101 | Q96SN8 | |
| QSEYNNLKSAIEKLT | 366 | Q8N442 | |
| KFEENYTSQNVLTKS | 251 | Q2M385 | |
| QANYTIQSLKDTKTT | 91 | Q9NZZ3 | |
| YVSQLKSVDKSSNRE | 816 | Q8WUM0 | |
| ISDLDSYKSNSKNNS | 111 | M0R2J8 | |
| QQELSSQKAAYESKI | 966 | Q15058 | |
| SQKDSKVDLIYQNTT | 1301 | Q12913 | |
| QTLVNSTSLYKNCKK | 146 | Q13478 | |
| VYAASSGQKKQQQSK | 286 | P58215 | |
| QTYDVASKEQQQSAK | 5161 | Q9NU22 | |
| LYQNAKRSSSESKKH | 316 | Q9UPQ8 | |
| KISSDIKSQNRFYTD | 881 | Q16706 | |
| YKSNQAQTVSERQKS | 686 | Q9P2D0 | |
| LSRKDNASNIYSKNT | 26 | Q8TBA6 | |
| VSKTNIKEYKDSFSN | 1226 | O75882 | |
| AYVKTSESLKQNNRD | 766 | Q8NCM2 | |
| ATESLAKYNNENTSK | 171 | Q9UGM5 | |
| SNYQDKSLSRNISLK | 656 | Q5SYE7 | |
| SEQAQSKFKSEKQNR | 701 | Q5T1M5 | |
| YNNILSDKNSSVNLK | 2216 | Q6KC79 | |
| QKYRSNKTQTVAVAA | 71 | Q6UWB1 | |
| ESYNEKTQQTSRKAF | 291 | Q0VF49 | |
| KYSEVKSRQTLQNAS | 1091 | O60449 | |
| KSRQTLQNASETVKY | 1096 | O60449 | |
| SALTDTQNAQYSKCK | 851 | Q8NEV8 | |
| KELKENIQTTNYNTA | 1531 | Q8NG31 | |
| SLQKSYEIVNKASQT | 1051 | A8MYU2 | |
| NSLKSYTSQKNERHK | 416 | P29728 | |
| FLEKKYLTATQNTKN | 311 | Q2PPJ7 | |
| ALSAVSTQQKKADRY | 271 | Q08379 | |
| YKNTQSNEDLKQEKS | 301 | Q08379 | |
| KSALNTRYSNEQKNK | 521 | Q9NY74 | |
| QKDTINNYEEKKTSS | 3021 | Q6V1P9 | |
| SLSSNLYEEVENNKK | 301 | Q96LP2 | |
| ISEVSSYVSANNKKN | 26 | Q96M15 | |
| VSFQKSQRFKQQKES | 36 | O75330 | |
| KQNNQSLASKKYQSD | 456 | Q96MT3 | |
| DVLEFYNSKKTSNSQ | 126 | Q13153 | |
| QDKQYEQNSLTAKTT | 1081 | Q52LW3 | |
| TSKNSNVKSYIKNNG | 41 | Q9H7U1 | |
| FYINTDNVKQSLSKK | 806 | Q9P2D7 | |
| KKRQTQSESSNYDSE | 806 | P46100 | |
| KSFENKYQEVSQKDS | 506 | Q92953 | |
| YTDKSAQNLASRNLK | 626 | P54132 | |
| SITKRDTQKSYSQQK | 41 | A0A1B0GVN3 | |
| DTQKSYSQQKSLNNA | 46 | A0A1B0GVN3 | |
| QTKYAQANSELSAKR | 596 | Q8NCX0 | |
| TKVNDTAARLSYQKN | 626 | Q14574 | |
| KAFTKTDQSKTNYIS | 971 | Q5THR3 | |
| KQNVAKYQSTSANSL | 261 | P57773 | |
| KYSSLASKAQDVQQS | 941 | Q4ZHG4 | |
| SKNKSNTIFSDSYIK | 936 | O75417 | |
| LQEKTGTYTTNKTKN | 1291 | O75417 | |
| SQISSGTQVEKYKKN | 1081 | Q9HC77 | |
| YKSKVSDLTQAANKN | 296 | P17661 | |
| SLQSSVQQYEEKNTK | 1206 | Q8IWJ2 | |
| AQKCKTYSTKTIQQD | 361 | Q15398 | |
| QDDKINKTYRSQLSS | 461 | Q5TB80 | |
| ADTYVATQSKKQNSL | 2136 | Q99698 | |
| NSYSKKTQSNNAENK | 421 | Q7KZI7 | |
| SQKYKSEKQDNFTQL | 1486 | Q9ULL0 | |
| NLTKISYVADKQQSR | 1531 | Q9ULL0 | |
| SQLSSNSLYAKAVKN | 406 | O60381 | |
| TADQLYIQSKKSQTK | 701 | D6RIA3 | |
| KYVQQEKQNTASLSK | 866 | Q56UN5 | |
| SAYIKNTQKEANKNF | 121 | O15247 | |
| QLTNDELSEKVKNYS | 226 | O75431 | |
| IQNAKAYLLKTSSNS | 211 | Q5TD94 | |
| KVNQKYITNKEEFTT | 251 | O95397 | |
| LTTTYTQKAKQAKLQ | 246 | Q9H987 | |
| KISETAQQKNFSYKD | 916 | O00268 | |
| AINLDSKSYDKTTQN | 396 | P49802 | |
| SSKEKNSKNTQYENL | 146 | Q96KW9 | |
| ISSKLNYTSSQEKTQ | 446 | Q96M34 | |
| NYTSSQEKTQAIVTK | 451 | Q96M34 | |
| QRRVSKNSKYNAEST | 306 | P49768 | |
| KNSKYNAESTERESQ | 311 | P49768 | |
| KQYESVSDLFNTKKS | 1816 | Q8WXH0 | |
| KREKNSESDQSTYSK | 666 | P30414 | |
| VYKNDQAAKDNPTKS | 561 | Q9UL63 | |
| KQSKYESSKESQQHS | 286 | P35251 | |
| TASYEQASQETRQKK | 1311 | Q9HCM1 | |
| TTVNLSENQLNKYAK | 566 | Q5QGS0 | |
| QKANKISYQSSSTEE | 341 | P04279 | |
| QKDVSQRSIYSQTEK | 366 | P04279 | |
| NSTYLNEKSLQLTEK | 66 | P61647 | |
| QQSQQKDYSSFLSRK | 406 | Q8N9S9 | |
| IKKQLSKYESQLSTN | 466 | Q13433 | |
| LEYKQKISKNSQNSN | 211 | A7E2S9 | |
| SNCSKQSIYKTIESK | 451 | P78536 | |
| KNAKSEASIYKNSLS | 681 | Q8TBZ0 | |
| NNNSKIKQESYEKAN | 96 | Q9UQC9 | |
| ALNYQSKSQKRSAVE | 276 | P98196 | |
| KYDVSSQVISQLKQK | 756 | P48736 | |
| LKEAYSVKSRLNQSQ | 846 | Q6P2Q9 | |
| ASLKNLETISNKQNY | 56 | O95455 | |
| TNSYSQALKLTKDKA | 26 | Q8IWX7 | |
| KTLKYNSDLLNSNRS | 111 | Q6P2D0 | |
| SKLNNTNIRNSEKVY | 211 | Q9H4F8 | |
| KEASYLVRNSETSKN | 341 | Q7M4L6 | |
| QISDYLKQSQEDLSK | 1656 | Q9BX84 | |
| ANSSRISNKSDYDKI | 496 | Q8NB66 | |
| KDYSTQTAQTLKQKL | 486 | Q6IEE8 | |
| NSADYSSESKKQKTE | 221 | Q04727 | |
| QASLKQDVCQSYSEK | 511 | Q9H6T3 | |
| KTYKANTLDNQLTNR | 106 | O95171 | |
| SKYIKNSDKGNRNNS | 451 | Q9BX26 | |
| KYSGQKNTENAKQSD | 701 | Q9BX26 | |
| VKENSSQSKKYSTQI | 26 | Q92670 | |
| KIQLKKDNSSTQVYN | 506 | Q92800 | |
| VNKYQQVKTDTSQES | 201 | Q9HAV4 | |
| VKKNSTTDQVYQAIA | 291 | Q96L92 | |
| KFQYQDNSKITRSTD | 761 | Q86WI1 | |
| QQQKDKAATQASKQY | 526 | Q8N841 | |
| NDTYSEVKSDLAQQK | 681 | Q13563 | |
| SKLTSLNVKYNNDKS | 256 | O95758 | |
| KDQLSEQTQKYSVSE | 1006 | Q9BZF9 | |
| TTTQNKIFQCDKYVK | 106 | Q9P255 | |
| TNNLKSLEAQAEKYS | 201 | P09493 | |
| VKENSSQSKKYSTKI | 26 | P51815 | |
| LQQKAQSLTKDVQSY | 391 | Q2M389 | |
| EYRKNSKVESSTRNN | 16 | Q9C0D7 | |
| YSLSEQQNDKNSKVL | 2611 | Q9BXT5 | |
| ENYLVKINTKANDTS | 1061 | Q7Z2W7 | |
| QTKDNKYTLNQTSAV | 446 | Q5VZ18 | |
| TNNLKSLEAQADKYS | 201 | P07951 | |
| SSNKESKVNNEKFRT | 1021 | Q5VUA4 | |
| TQSDLYKKTQETLSQ | 121 | O43399 | |
| YKKTQETLSQAGQKT | 126 | O43399 | |
| KVVKQSYEFSNSKKN | 106 | Q2M3W8 | |
| TKQQTKQNCTKRYIT | 821 | Q5FWF4 | |
| NEKKQQSSLYLTASQ | 86 | A0A087WSZ9 | |
| KKYILQATNTRTNSN | 1401 | P82987 | |
| TNKTKNKGVYSSTNE | 406 | O75113 | |
| KTEKTSSVQSDKKYN | 806 | Q86UW6 | |
| TVLQNFSSDKKYKDS | 411 | P20929 | |
| SVNQSDVKYKETFNK | 4416 | P20929 |